PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Sadhna Sharma Selected Research

Tuberculosis

02/2008	Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.
09/2007	Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis.
10/2005	Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.
12/2004	Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis.
10/2004	Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
08/2004	Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis.
04/2004	Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
12/2003	Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
09/2003	Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.
04/2003	Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.
01/2003	Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
10/2002	Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.

Articles by Research Topic

Disease

12	Tuberculosis 02/2008 - 10/2002
2	Infection 04/2007 - 01/2004
1	Necrosis 08/2004
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 08/2004

Drug/Important Bio-Agent (IBA)

3	alginic acid (sodium alginate)IBA 09/2007 - 04/2003
3	Antitubercular AgentsIBA 09/2007 - 01/2003
3	Liposomes (Liposome)IBA 04/2004 - 10/2002
2	Drug CarriersIBA 10/2005 - 10/2004
2	Carbon MonoxideIBA 12/2004 - 12/2003
2	poly(lactide) (polylactide)IBA 12/2004 - 12/2003
2	Polyglactin 910IBA 10/2004 - 09/2003
2	Rifampin (Rifampicin)FDA LinkGeneric 09/2003 - 10/2002
2	Isoniazid (Ftivazide)FDA LinkGeneric 09/2003 - 10/2002
1	Econazole FDA LinkGeneric 02/2008
1	moxifloxacin (Avelox)FDA Link 02/2008
1	Interferon-gamma (Interferon, gamma)IBA 04/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2004
1	Pyrazinamide FDA LinkGeneric 09/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 02/2008 - 04/2004